Abbott clinical biochemical second-generation alkaline phosphatase assay group - Taiwan Registration ec162c9afcee9f24aa0fc56980018956
Access comprehensive regulatory information for Abbott clinical biochemical second-generation alkaline phosphatase assay group in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number ec162c9afcee9f24aa0fc56980018956 and manufactured by ABBOTT IRELAND DIAGNOSTICS DIVISION. The authorized representative in Taiwan is ABBOTT LABORATORIES SERVICES LLC TAIWAN BRANCH (U.S.A.).
This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.
Device Details
Product Details
This product is used on the ARCHECT c system to quantify alkaline phosphatase in human serum or plasma.
A Clinical chemistry and clinical toxicology
A.1050 Alkaline phosphatase or isoenzyme testing system
QMS/QSD;; ่ผธๅ ฅ
Dates and Status
Sep 30, 2022
Sep 30, 2027

